Case Reports
doi: 10.1007/BF03343758.
The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production
Affiliations
- PMID: 11005273
- DOI: 10.1007/BF03343758
Item in Clipboard
Case Reports
The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production
J Endocrinol Invest.
2000 Jul-Aug.
Abstract
We present a case of a patient suffering from metastatic differentiated thyroid carcinoma (DTC) and insufficient endogenous TSH production suspicious of secondary hypothyroidism. The use of recombinant human TSH (rhTSH) enabled us to administer a therapeutic activity of radioactive iodine (RAI) under maximal TSH-stimulation, achieving a marked decrease in thyroglobulin accompanied by a clinical improvement.
Similar articles
-
Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy.Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):367-73. doi: 10.1007/s00259-002-1076-y. Epub 2002 Dec 19. Eur J Nucl Med Mol Imaging. 2003. PMID: 12634964 Clinical Trial.
-
Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.J Clin Endocrinol Metab. 1999 Nov;84(11):3867-71. doi: 10.1210/jcem.84.11.6161. J Clin Endocrinol Metab. 1999. PMID: 10566621 No abstract available.
-
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?Thyroid. 2010 Jan;20(1):15-23. doi: 10.1089/thy.2008.0416. Thyroid. 2010. PMID: 20017617
-
Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.J Endocrinol Invest. 1999;22(11 Suppl):30-4. J Endocrinol Invest. 1999. PMID: 10727003 Review.
-
[Recombinant human TSH use in differentiated thyroid cancer].Arq Bras Endocrinol Metabol. 2007 Jul;51(5):806-12. doi: 10.1590/s0004-27302007000500018. Arq Bras Endocrinol Metabol. 2007. PMID: 17891244 Review. Portuguese.
Cited by
-
Analysis of Clinical Factors for the Determination of Optimal Serum Level of Thyrotropin After Recombinant Human Thyroid-Stimulating Hormone Administration.Nucl Med Mol Imaging. 2015 Dec;49(4):268-75. doi: 10.1007/s13139-015-0348-y. Epub 2015 Sep 1. Nucl Med Mol Imaging. 2015. PMID: 26550045 Free PMC article.
-
Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone.J Endocrinol Invest. 2002 Jan;25(1):44-52. doi: 10.1007/BF03343960. J Endocrinol Invest. 2002. PMID: 11883865
-
Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1077-86. doi: 10.1007/s00259-003-1190-5. Epub 2003 May 29. Eur J Nucl Med Mol Imaging. 2003. PMID: 12783219 Clinical Trial.
-
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD008302. doi: 10.1002/14651858.CD008302.pub2. Cochrane Database Syst Rev. 2010. PMID: 21069705 Free PMC article.
-
Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy.Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):367-73. doi: 10.1007/s00259-002-1076-y. Epub 2002 Dec 19. Eur J Nucl Med Mol Imaging. 2003. PMID: 12634964 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
